Top Story

IG-IMRT showed favorable outcomes in skull base chordoma, chondrosarcoma

January 19, 2015

Patients with chordomas or chondrosarcomas of the skull base had favorable 5-year OS and local control after high-dose image-guided intensity-modulated radiation therapy, according to study results.

Arjun Sahgal, MD, of the department of radiation oncology at Sunnybrook Odette Cancer Centre in Toronto, and colleagues administered high-dose IG-IMRT to 42 consecutive patients with either skull base chordoma (n=24) or chondrosarcoma (n=18) who were treated between August 2001 and December 2012.

Meeting News Coverage

Preoperative transcutaneous oximetry predicted complications in sarcoma radiation

November 21, 2014
The use of preoperative transcutaneous oximetry may be useful in predicting wound-healing complications in patients undergoing surgery for soft tissue sarcomas after…
FDA News

FDA grants fast track designation to TH-302 for metastatic soft tissue sarcoma

November 11, 2014
The FDA granted fast track designation to TH-302 as a potential treatment for previously untreated patients with metastatic or locally advanced unresectable soft tissue…
In the Journals

Shorter therapy did not compromise outcomes in low-risk embryonal rhabdomyosarcoma

October 30, 2014
Shorter-duration therapy with vincristine, dactinomycin and lower-dose cyclophosphamide with radiation therapy did not compromise failure-free survival in patients with…
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »

Filter By:

In the Journals

IG-IMRT showed favorable outcomes in skull base chordoma, chondrosarcoma

January 19, 2015
Patients with chordomas or chondrosarcomas of the skull base had favorable 5-year OS and local control after high-dose image-guided…
Meeting News Coverage

Preoperative transcutaneous oximetry predicted complications in sarcoma radiation

November 21, 2014
The use of preoperative transcutaneous oximetry may be useful in predicting wound-healing complications in patients undergoing surgery for soft…
FDA News

FDA grants fast track designation to TH-302 for metastatic soft tissue sarcoma

November 11, 2014
The FDA granted fast track designation to TH-302 as a potential treatment for previously untreated patients with metastatic or locally advanced…
In the Journals

Shorter therapy did not compromise outcomes in low-risk embryonal rhabdomyosarcoma

October 30, 2014
Shorter-duration therapy with vincristine, dactinomycin and lower-dose cyclophosphamide with radiation therapy did not compromise failure-free…
In the Journals

IMRT reduced recurrence rates in primary soft tissue sarcoma

September 26, 2014
Patients with primary soft tissue sarcomas of the extremity who underwent intensity-modulated radiation therapy experienced significantly reduced…
In the Journals

TH-302 demonstrates encouraging activity in soft tissue sarcoma

September 23, 2014
The investigational hypoxia-targeted drug TH-302 was associated with PFS, OS and tumor response rates that compared favorably with other first-line…
In the Journals

Survivors of osteosarcoma at increased risk for second malignant neoplasms

August 28, 2014
Survivors of osteosarcoma demonstrated an increased risk for second malignant neoplasms, and the risk persisted long after the conclusion of…
In the Journals

Tumor size, location, grade predicted late recurrence in soft tissue sarcoma

August 6, 2014
Late recurrence in most patients treated for soft tissue sarcoma is uncommon, according to study results.However, the findings suggest long-term…
FDA News

FDA accepts first application for biosimilar filgrastim

July 28, 2014
Sandoz Inc. recently announced that the FDA has accepted its Biologics License Application for filgrastim, which was filed under the new biosimilar…
In the Journals

Time to diagnosis not associated with survival in adolescents with Ewing tumors

June 27, 2014
The time to diagnosis of Ewing tumors was long and did not improve over time, but it did not appear to affect survival, surgical outcome or…
More Headlines »
morganatic-roan